Glaxo Executive’s Memo Suggested Burying Drug Studies
An executive of GlaxoSmithKline Plc, the world’s second-biggest drugmaker, talked about burying negative studies linking its antidepressant drug Paxil to birth defects, according to a company memo introduced at a trial.
Read article at bloomberg.com
Saturday, September 26, 2009
GlaxoSmithKline Executive’s Memo Suggested Burying Drug Studies
Subscribe to:
var sc_project=1725605;
var sc_invisible=0;
var sc_partition=16;
var sc_security="acf71b9a";